ORKA Stock Analysis: Buy, Sell, or Hold?
ORKA - Oruka Therapeutics, Inc. Common Stock
$85.10
1.70 (2.04%)
▲
5d:
+25.68%
30d:
+40.41%
90d:
+113.28%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ORKA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ORKA is 18.1% above its trading range ($72.07). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ORKA is 18.1% above its trading range ($72.07). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ORKA is currently trading at $85.10, which is considered extended relative to its 30-day fair value range of $56.10 to $72.07.
Technical Outlook: Technically, ORKA is in a strong uptrend. Immediate support is located at $62.55, while resistance sits at $88.83.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $142.17 (+70.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ORKA is in a strong uptrend. Immediate support is located at $62.55, while resistance sits at $88.83.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $142.17 (+70.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$56.10 -
$72.07
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+18.1% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 70.5% below Wall St target ($142.17)
Trading Range Analysis
30-Day Trading Range
$56.10 -
$72.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$62.55
Resistance Level
$88.83
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-33.87
Wall Street Target
$142.17
(+70.5%)
Share & Embed Analysis
Last updated: June 24, 2026 11:41 AM ET
Data refreshes hourly during market hours. Next update: 12:41 PM
Data refreshes hourly during market hours. Next update: 12:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORKA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Joana Goncalves
SELL
7000 shares
2026-04-15
Arjun Agarwal
SELL
395 shares
2026-03-16
Joana Goncalves
SELL
7641 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
